DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: Safety, efficacy, and challenges Editorial

   


Authors: Bellis, R. Y.; Adusumilli, P. S.; Amador-Molina, A.
Title: DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: Safety, efficacy, and challenges
Keywords: unclassified drug; drug efficacy; nonhuman; antigen expression; t lymphocyte; lung cancer; notch receptor; editorial; cancer inhibition; immunotherapy; natural killer cell; cross reaction; small cell lung cancer; phase 1 clinical trial (topic); small cell lung cancer (sclc); immune checkpoint inhibitor; preclinical study; human; gene editing; chimeric antigen receptor t-cell immunotherapy; tarlatamab; delta like ligand 3; chimeric antigen receptor t-cell (car t-cell); delta-like ligand 3 (dll3)
Journal Title: Translational Lung Cancer Research
Volume: 13
Issue: 3
ISSN: 2218-6751
Publisher: Translational Lung Cancer Research  
Date Published: 2024-03-29
Start Page: 694
End Page: 698
Language: English
DOI: 10.21037/tlcr-23-820
PROVIDER: scopus
PMCID: PMC11002519
PUBMED: 38601455
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189292303&doi=10.21037%2ftlcr-23-820&partnerID=40&md5=026a9c4d83fb891d2865b1bf8b6ec228
Notes: Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Prasad S Adusumilli
    496 Adusumilli
  2. Rebecca Bellis
    11 Bellis
  3. Alfredo Amador Molina
    8 Amador Molina
Related MSK Work